Antiarrhythmic Effects of Potassium Channel Openers in Rhythm Abnormalities Related
to Delayed Repolarization Leif Carlsson, PhD; Christina Abrahamsson; Lissen Drews; and Goran Duker, PhD Background. Earlier observations have indicated that repolarization-delaying agents may, under certain circumstances, have the propensity to induce polymorphous ventricular tachyarrhythmias (PVTs) (i.e., torsade de pointes). We have studied whether the potassium channel opener pinacidil and two of its pyridylcyanoguanidine analogues (P1075 and P1188) have any antiarrhythmic effects on clofilium-induced PVTs and triggered responses in rabbits in vivo and in vitro.
Methods and Result. Anesthetized rabbits were pretreated with propranolol (2 ,umollkg i.v.) and subsequently given a concomitant intravenous infusion of clofilium (63 nmol/kg/min for maximally 15 minutes) and the et,-agonist methoxamine (70 nmol/kg/min). In vehicle-pretreated rabbits (n=19), clofilium invariably induced PVTs, which closely resembled torsade de pointes and were preceded by a marked prolongation of the QTU interval (27+2.4,op<0.001). In a separate group of seven rabbits in which monophasic action potentials were recorded from the left ventricular endocardium, the tachyarrhythmia was preceded by deflections consistent with early afterdepolarizations (EADs) of the plateau repolarization phase of the monophasic action potentials. Intravenous administration of the pyridylcyanoguanidines in doses reducing mean arterial blood pressure by 25 or 50 mm Hg, respectively, was associated with a dose-dependent attenuation in the occurrence of clofilium-induced PVTs. In the pinacidil-pretreated rabbits (0.41 ,moV/kg or 1.86 ,umoU/kg i.v.), the occurrence of PVTs was reduced from seven of seven rabbits to five of six and to three of seven rabbits (p=0.035 versus vehicle-pretreated controls), respectively. In rabbits pretreated with the low dose of P1075 (0.01 ,umollkg i.v.), PVT occurrence was reduced from six of six rabbits to two of six rabbits (p=0.030), whereas in six rabbits given the high dose of P1075 (0. 13, umoVkg) , no PVTs appeared (p=0.001). When the sulfonylurea glibenclamide (10 ,umolVkg i.v.) was administered to rabbits before P1075 (0.13 ,gmoI/kg) was infused, clofilium induced PVTs in five of six rabbits (not significantly different from the incidence in the vehicle-pretreated rabbits). Pretreatment with P1188 (436 gmol/kg or 11.88,umol/kg iv.) caused a reduction in the occurrence of PVT from six of six rabbits to five of six and to none of six rabbits (p=0.001), respectively. In the six animals pretreated with the high dose of P1188 in which no clofilium-induced arrhythmias were elicited, glibenclamide (20,mol/kg i.v.) was injected after the entire dose of clofilium had been administered.
In these rabbits, premature ventricular systoles and PVTs appeared within a few minutes in five and four of the animals, respectively. In contrast to the pyridylcyanoguanidines, diltiazem pretreatment (0.9 1£moVkg i.v., decreasing arterial pressure by 50 mm Hg) did not attenuate PVT occurrence (five of six rabbits). Acute administration of P1075 (0.13,umoV/kg) during recurrent attacks of PVTs abruptly regularized the rhythm in 12 of 13 animals and diminished EADs observed in monophasic action potentials recorded from the left ventricular endocardium. In in vitro experiments, action potentials were simultaneously recorded from rabbit mechanism underlying torsade de pointes.S34 Among antiarrhythmic agents, quinidine is the most frequently cited culprit in torsade de pointes, although most 
In Vivo Experiments
Male New Zealand White rabbits (2.5-3.5 kg body wt) were used in this study. Anesthesia was initiated with methohexital-sodium (Brietal 5 mg/kg) injected via a marginal ear vein and followed by infusion of a-chloralose (90 mg/kg, infusion volume 9 ml) administered for 20 minutes. No further anesthetic was needed. After tracheotomy, the animal was artificially ventilated with room air with a ventilator for small animals constructed in our laboratory. Blood gases and pH were kept within the physiological range by adjustments of tidal volume and respiratory frequency. Catheters were implanted into the right carotid artery and the jugular veins for recording of arterial blood pressure and infusion of drugs, respectively. Potassium levels in the arterial blood were estimated by means of a sodiumpotassium analyzer (KNA1, Radiometer, Copenhagen, Denmark). Standard surface electrocardiograms (ECGs) (leads I-III, aVL, aVR, and aVF) were recorded on a Mingograph ink-jet recorder (Mingocard 7, Siemens-Elema, Sweden), and arterial blood pressure and heart rate were recorded on a Grass polygraph ( 
Electrocardiographic Measurements
As soon as the infusion of clofilium had been initiated, surface ECGs were sampled for 5 seconds by the computer once every minute. All complexes during the 5-second sampling period were then analyzed, and the averaged ECG (lead I) was used for measurement of the QTU interval. Normally, a splitting of the T wave into two separate peaks (TU complex) could be seen in the ECG. The QTU interval was defined as the time between the first deviation from the isoelectric line during the PR interval until the peak of the TU wave.
In Vitro Experiments
In the in vitro study, male rabbits of the Russian strain (2.0-2.3 kg body wt) were used. The animal was anesthetized with pentobarbitone sodium (60 mg/kg i.v.), and the heart was excised and placed in a hyperkalemic and hypertonic solution of the following composition (in mM): NaCl 131, NaHCO3 18, CaCl2 2.5, MgCl2 0.5, NaH2PO4 0.9, KCI 27, glucose 55.
The right ventricular anterior papillary muscle with its free-running Purkinje fibers was excised and cut longitudinally. The preparation was mounted in a 2-ml organ bath (Steiert organ bath, Hugo Sachs Elektronik, March-Hugstetten, FRG) and superfused at a constant flow of 11 ml/min. After 1 hour, including the time for preparation, the solution was changed to a modified Tyrode's solution containing (in mM): NaCl 130, NaHCO3 18, CaCl2 1.8, MgSO4 0.5, NaH2PO4 1.8, KCl were also recorded on a strip chart recorder (Graphtec WR 3600, Graphtec Corporation, Tokyo) at a paper speed of 100 mm/sec.
To mimic the conditions in the in vivo experiments in which clofilium was continuously infused into rabbits, an experimental approach was used in which the concentration of clofilium in the superfusate was continuously increased over time. After a period when control recordings were made, clofilium was continuously added to the reservoir containing Tyrode's solution flowing into the organ bath. With a certain volume in the reservoir and a known inflow of clofilium and rate of outflow of solution, the increase of the concentration of clofilium in the reservoir, and thereby in the organ bath, could be calculated and was set to 50 nmol/min. During the administration of clofilium, action potentials were recorded at various intervals until EADs appeared. When EADs arose, the addition of clofilium was stopped, and the clofilium concentration in the superfusate was subsequently maintained at that particular level. Immediately after the clofilium infusion was interrupted, superfusion with P1075, with the same rate of increase of concentration as for clofilium, was started. This superfusion was continued until the EADs disappeared and, as for clofilium, the concentration of P1075 in the reservoir was then maintained. Recordings were made as soon as the EADs had vanished. The superfusate now contained clofilium at a concentration that induced EADs in the absence of P1075 and P1075 at a concentration that suppressed the clofilium-induced EADs. Under these conditions, 10 
Characterization of Tachyarrhythmia In Vivo
In nineteen vehicle-pretreated rabbits, the concomitant infusion of clofilium and methoxamine was invariably (19 of 19) associated with the appearance of premature ventricular systoles, which, after a short lag phase in all animals, turned into PVT. The mean cumulative dose of clofilium administered at the time of the onset of the first premature ventricular systole was 0.4±0.05 gmol/kg, whereas the first PVT episode was observed after a mean cumulative dose of 0.6±0.05 gmol/kg. The first premature ventricular systole was preceded by a substantial lengthening of the QTU interval and RR interval (from 131+3.3 to 164±3.5 msec, p<0.001 and from 271±8.4 to 305±+11.6 msec, p<0.001, respectively; n=19). In 17 of the 19 vehicletreated rabbits, it was possible to determine the cycle length changes just before the onset of the first episode of the PVT. The tachyarrhythmia was initiated in a consistent mode with a premature ventricular beat followed by a postectopic pause and a subsequent supraventricular beat, which in turn was followed by a premature depolarization interrupting the T wave (Figure 1) . The relations between the long (initiating) cycle length and the short cycle lengths are illustrated in Figure 2 . The PVT, normally self-terminating, showed a typical "twisting morphology" with oscillating peaks of sequential QRS complexes (Figure 1) .
In seven rabbits studied separately, clofilium induced a significant prolongation of the endocardial monophasic APD without affecting the rise time of the monophasic action potential. In Figure 3 Clofilium (nmollkg) Figure 5C ). The lack of PVTs in these P1188-and P1075-pretreated rabbits was observed despite a significant prolongation of the QTU interval by clofilium. PVTs were induced in five of the six animals, a PVT occurrence not significantly different from the one observed in the vehicle-pretreated animals ( Figure SC) . In the group of six rabbits pretreated with the high dose of P1188 and in which no clofilium-induced dysrhythmias appeared ( Figure 5B), glibenclamide (20 ,umol/kg i.v.) was given as a bolus injection after the entire dose of clofilium had been administered. In these six rabbits, premature ectopic beats appeared within a few minutes in five animals and PVTs in four.
In Vitro Results
The values of the baseline APD (at 75% repolarization) in ventricular muscle cells and in Purkinje fibers were 119±4.2 msec and 284±5.2 msec, respectively. The effects of an increasing concentration of clofilium on the APD in ventricular muscle cells and in Purkinje fibers are shown in Figure 6 . During superfusion with clofilium, the APD in Purkinje fibers showed a gradual prolongation until EADs eventually developed ( Figure  7 , panels A-C). In four of six preparations, EADs propagated and initiated triggered responses in ventricular muscle cells ( Figure 7C ). Clofilium concentration at the time when EADs first appeared in Purkinje fibers was 1.1±0.17 ,.tM (n-=6), and maximum APD in Purkinje fibers preceding EADs was 603±35.5 msec (p<O.OOl versus pre-drug duration). The APD in the ventricular muscle cells was not significantly affected by clofilium. Hence, the action potentials recorded simultaneously with the longest action potentials in Purkinje fibers had a duration of 124±5.2 msec.
Administration of P1075 was associated with a shortening of the clofilium-induced APD prolongation and a gradual disappearance of clofilium-induced EADs. The APD in Purkinje fibers was, however, still markedly longer than it was before the administration of clofilium ( Figure 7D ). The final concentration of P1075 at which Addition of glibenclamide (in the presence of clofilium and P1075) resulted in a rapid prolongation of the APD in Purkinje fibers in four of the six preparations (to 615±67.3 msec), and within 2.5-5.5 minutes, the duration was prolonged markedly and EADs eventually reappeared (Figure 8) .
To further confirm the characteristic features of clofilium-induced EADs, the influence of the stimulation frequency was examined in three of the six experiments. An increase in the stimulation frequency was associated with a gradual suppression and finally a disappearance of the clofilium-induced EADs. Furthermore, when the stimulation was interrupted for various time periods, the number of EADs after the first post-pause-stimulated action potential increased with the length of the pause, i.e., the APD was further increased by the reduction in frequency and more EADs developed during the plateau phase ( Figure 9 ). Discussion Observations from this study have demonstrated that ventricular rhythm abnormalities related to delayed repolarization can effectively be prevented or suppressed by the potassium channel opener pinacidil and its related pyridylcyanoguanidine derivatives P1075 and P1188. The main part of the study was performed in an animal model of the acquired long QT syndrome in which action potential-prolonging agents induce a form of PVT closely resembling clinical torsade de pointes.5 Hence, the tachyarrhythmia was preceded by a marked prolongation of the QTU interval as well as lengthening of the endocardial monophasic APD, a distinct prominent U wave, deflections in the late repolarization phase of the monophasic action potential, a consistent mode of initiation ("short-long-short sequence"), and the typical undulating morphology of sequential QRS complexes. Although the antiarrhythmic effect of the potassium channel openers may seem predictable in view of their properties of increasing membrane potassium conductance (thereby shortening the APD), it was of interest to note that pretreatment with P1075 or P1188 prevented PVTs despite a clofilium-induced QTU prolongation that did not differ significantly from the lengthening observed in the vehicle-pretreated rabbits. Similarly, acute intervention with P1075 caused a prompt regularization of rhythm with only a modest reduction in the clofilium-induced monophasic action potential lengthening. Moreover, in isolated Purkinje fibers, P1075 caused a suppression of EADs and triggered activity despite a substantial clofilium-induced prolongation of the APD. Concordant results were recently presented by Fish and coworkers6 in a study in which EADs and triggered activity were elicited in canine Purkinje fibers during superfusion with quinidine, cesium, or sematilide. In that study, two structurally unrelated potassium channel openers, pinacidil and cromakalim, were demonstrated to abolish rhythm abnormalities related to delayed repolarization at concentrations that did not reverse the primary drug-induced action potential prolongation. studies, it was obvious that clofilium caused a substantial prolongation of the APD in the Purkinje fiber, whereas the duration in the ventricular muscle cell was almost unaffected, thus causing an increased dispersion of repolarization. Under conditions of increased dispersion of repolarization, which may be a consequence of treatment with repolarization-delaying agents, areas with different APDs occur, and electrical gradients are thus generated. In such a situation, current can flow from structures with lower membrane voltages to structures with higher membrane voltages and thus electrotonically depolarize the latter structure, a phenomenon denoted "prolonged repolarization-dependent reexcitation" by Brugada and Wellens.19 Data were recently presented in support of the hypothesis that QT interval dispersion reflects differences in myocardial repolarization times and that such a QT dispersion may distinguish between patients susceptible to ventricular arrhythmias and patients without arrhythmias. 20 An indication of an increased dispersion of repolarization was also found in the present study, in which clofilium caused a marked increase in the amplitude of the U wave. The origin of the U wave has been a subject of discussion and dispute for a long time. One hypothesis relates the U wave of the surface ECG to EADs,3,2' whereas Hoffman and Cranefield22 suggested that the U wave is a manifestation of the repolarization of Purkinje fibers. This latter hypothesis has been questioned because the small mass of Purkinje fiber network should not be able to generate enough current during the repolarization process to be detected on the standard ECG. Recently, however, evidence was 27 However, in a model of ouabain-induced arrhythmias, no antiarrhythmic effects of pinacidil could be documented. In contrast to the studies demonstrating suppressive effects of potassium channel openers on arrhythmias of various origins, other studies have pointed out the fact that such agents can actually induce or contribute to the genesis of tachyarrhythmias. In isolated canine Purkinje fibers, high concentrations of pinacidil exacerbated barium-induced automaticity, and in some preparations, episodes of spontaneous tachycardia developed.9 Furthermore, pinacidil has also been demonstrated to produce a marked dispersion of repolarization within epicardial tissue and also between epicardial and endocardial canine tissue, which in turn augmented reentrant arrhythmias.28 Chi and coworkers10 recently demonstrated that, in the conscious dog, pinacidil may exert a profibrillatory effect in the postinfarcted heart during superimposition of an acute ischemic event. It was hypothesized that the increased tendency to develop ventricular fibrillation was a con-sequence of a pinacidil-induced attenuation of ventricular refractoriness.
Despite the dissimilarity of their chemical structures, most potassium channel openers appear to mediate their myocardial effects by opening plasmalemma ATPregulated potassium channels.",1329 Mammalian heart cells from various species have high-affinity receptors for antidiabetic sulfonylureas such as glibenclamide, an established blocker of the ATP-regulated potassium channel. 30 Our data indicate that the antiarrhythmic effects of pinacidil and its derivatives are mediated via activation of the ATP-dependent potassium channel. In the anesthetized rabbit, pretreatment with glibenclamide antagonized the antiarrhythmic effect of P1075 and, furthermore, in rabbits given P1188 and in which clofilium did not initiate tachyarrhythmias, infusion of glibenclamide led to recurrent episodes of tachyarrhythmias. These observations were confirmed in the in vitro recordings in which glibenclamide reversed the suppressive effects of P1075 on clofilium-induced EADs and triggered activity. Fish and colleagues6 suggested that the major antiarrhythmic principle of potassium channel openers in arrhythmias related to delayed repolarization is an acceleration of repolarization, which may inhibit the depolarizing current responsible for the triggered response or increase the current needed to elicit the afterdepolarization and the triggered response. Evidence in support of this hypothesis was recently put forward by Spinelli and others,7 who demonstrated that the depolarizing current needed to elicit an EAD was markedly increased by pinacidil; furthermore, in single canine myocytes, pinacidil was found to abolish EADs caused by BAY K 8644 or ketanserin. Vasodilation and/or altered loading conditions may be referred to as an alternative explanation, because administration of the potassium channel openers in the in vivo experiments was associated with a substantial fall in blood pressure. Hansen and others3' recently stressed the importance of mechanoelectrical feedback for induction of arrhythmias in globally dilated or dyskinetic ventricles. However, the lack of effect of diltiazem in the present study suggests that the antiarrhythmic effects of potassium channel openers are independent of changes in load or dilatation.
Conclusions
Our study indicates that EADs, triggered activity, and increased dispersion of repolarization may be important factors contributing to torsade de pointes associated with acquired long QT syndrome. The reliability of the rabbit treated with class III antiarrhythmic agents as a useful experimental model of acquired long QT syndrome has been additionally confirmed. Furthermore, the results demonstrate that activation of ATPdependent (glibenclamide-sensitive) potassium channels can suppress rhythm abnormalities related to delayed repolarization and may be a novel therapeutic approach in the treatment of torsade de pointes.
